Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Operating Margin (2020 - 2026)

RxSight filings provide 6 years of Operating Margin readings, the most recent being 87.98% for Q4 2025.

  • On a quarterly basis, Operating Margin rose 3210.0% to 87.98% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.07%, a 196.0% decrease, with the full-year FY2025 number at 6.07%, down 196.0% from a year prior.
  • Operating Margin hit 87.98% in Q4 2025 for RxSight, up from 40.14% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 101.57% in Q4 2023 to a low of 319.6% in Q1 2021.
  • Median Operating Margin over the past 5 years was 60.92% (2023), compared with a mean of 84.75%.
  • Biggest five-year swings in Operating Margin: crashed -26216bps in 2021 and later skyrocketed 19475bps in 2023.
  • RxSight's Operating Margin stood at 174.02% in 2021, then soared by 46bps to 93.18% in 2022, then soared by 209bps to 101.57% in 2023, then plummeted by -45bps to 55.89% in 2024, then surged by 57bps to 87.98% in 2025.
  • The last three reported values for Operating Margin were 87.98% (Q4 2025), 40.14% (Q3 2025), and 41.63% (Q2 2025) per Business Quant data.